1. Home
  2. QTTB vs RDNW Comparison

QTTB vs RDNW Comparison

Compare QTTB & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$8.51

Market Cap

265.2M

Sector

Health Care

ML Signal

N/A

Logo RideNow Group Inc.

RDNW

RideNow Group Inc.

N/A

Current Price

$4.42

Market Cap

213.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
QTTB
RDNW
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
265.2M
213.0M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
QTTB
RDNW
Price
$8.51
$4.42
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
★ $39.67
$5.25
AVG Volume (30 Days)
★ 322.9K
56.3K
Earning Date
11-04-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 136.78
37.84
EPS
N/A
★ N/A
Revenue
$53,737,000.00
★ $1,793,369,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.05
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 91.10
52 Week Low
$1.93
$4.14
52 Week High
$23.57
$8.55

Technical Indicators

Market Signals
Indicator
QTTB
RDNW
Relative Strength Index (RSI) 41.77 34.31
Support Level $8.23 N/A
Resistance Level $9.41 $7.14
Average True Range (ATR) 0.54 0.45
MACD -0.01 -0.09
Stochastic Oscillator 20.24 16.07

Price Performance

Historical Comparison
QTTB
RDNW

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

About RDNW RideNow Group Inc.

RideNow Group Inc operates solely as a powersports dealership group. Its offerings include new and pre-owned vehicles such as motorcycles, all-terrain vehicles (ATVs), side-by-side vehicles (SXS), and personal watercraft (PWC). It also sells parts, apparel, and accessories, and provides financing, insurance, and aftermarket products, along with repair and maintenance services. The majority of the company's revenue is derived from powersports vehicle sales, and the rest from parts, service and accessories/merchandise, and finance and insurance products.

Share on Social Networks: